Mayo Clinic Laboratory and Pathology Research Roundup: June 27

The Research Roundup provides an overview of the past week’s research from Mayo Medical Laboratories consultants, including a featured article of the week, abstracts, and complete list of published studies and reviews.

Featured Study of the Week

Prognostic Value of Circulating Tumor Cell Enumeration in Patients with Cholangiocarcinoma

CTCs-960x540Cholangiocarcinoma (CCA) is the second most common cause of primary liver cancer. Currently, useful prognostic and predictive biomarkers for CCA do not exist, resulting in diagnosis at an advanced stage with no effective treatment options. Circulating tumor cells (CTCs) in the peripheral blood are associated with various types of cancer. Mayo Clinic researchers hypothesized that CTCs are also associated with poor survival of patients with CCA. The study was published in the Hepatology journal.

Published to PubMed This Week

brentwestra (@brentwestra)


Brent Westra is a Marketing Segment Manager at Mayo Clinic Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.